Literature DB >> 11598085

Potential role for a carbohydrate moiety in anti-Candida activity of human oral epithelial cells.

C Steele1, J Leigh, R Swoboda, H Ozenci, P L Fidel.   

Abstract

Candida albicans is both a commensal and a pathogen at the oral mucosa. Although an intricate network of host defense mechanisms are expected for protection against oropharyngeal candidiasis, anti-Candida host defense mechanisms at the oral mucosa are poorly understood. Our laboratory recently showed that primary epithelial cells from human oral mucosa, as well as an oral epithelial cell line, inhibit the growth of blastoconidia and/or hyphal phases of several Candida species in vitro with a requirement for cell contact and with no demonstrable role for soluble factors. In the present study, we show that oral epithelial cell-mediated anti-Candida activity is resistant to gamma-irradiation and is not mediated by phagocytosis, nitric oxide, hydrogen peroxide, and superoxide oxidative inhibitory pathways or by nonoxidative components such as soluble defensin and calprotectin peptides. In contrast, epithelial cell-mediated anti-Candida activity was sensitive to heat, paraformaldehyde fixation, and detergents, but these treatments were accompanied by a significant loss in epithelial cell viability. Treatments that removed existing membrane protein or lipid moieties in the presence or absence of protein synthesis inhibitors had no effect on epithelial cell inhibitory activity. In contrast, the epithelial cell-mediated anti-Candida activity was abrogated after treatment of the epithelial cells with periodic acid, suggesting a role for carbohydrates. Adherence of C. albicans to oral epithelial cells was unaffected, indicating that the carbohydrate moiety is exclusively associated with the growth inhibition activity. Subsequent studies that evaluated specific membrane carbohydrate moieties, however, showed no role for sulfated polysaccharides, sialic acid residues, or glucose- and mannose-containing carbohydrates. These results suggest that oral epithelial cell-mediated anti-Candida activity occurs exclusively with viable epithelial cells through contact with C. albicans by an as-yet-undefined carbohydrate moiety.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11598085      PMCID: PMC100093          DOI: 10.1128/IAI.69.11.7091-7099.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  63 in total

Review 1.  The selectins and their ligands.

Authors:  S D Rosen; C R Bertozzi
Journal:  Curr Opin Cell Biol       Date:  1994-10       Impact factor: 8.382

Review 2.  The leucocyte protein L1 (calprotectin): a putative nonspecific defence factor at epithelial surfaces.

Authors:  P Brandtzaeg; T O Gabrielsen; I Dale; F Müller; M Steinbakk; M K Fagerhol
Journal:  Adv Exp Med Biol       Date:  1995       Impact factor: 2.622

3.  Antigen-presenting cells in the female reproductive tract: influence of the estrous cycle on antigen presentation by uterine epithelial and stromal cells.

Authors:  C R Wira; R M Rossoll
Journal:  Endocrinology       Date:  1995-10       Impact factor: 4.736

4.  Differential susceptibility of two species of macaques to experimental vaginal candidiasis.

Authors:  C Steele; M Ratterree; P L Fidel
Journal:  J Infect Dis       Date:  1999-09       Impact factor: 5.226

5.  T helper cell type 1 (Th1)- and Th2-like responses are present in mice with gastric candidiasis but protective immunity is associated with Th1 development.

Authors:  E Cenci; A Mencacci; R Spaccapelo; L Tonnetti; P Mosci; K H Enssle; P Puccetti; L Romani; F Bistoni
Journal:  J Infect Dis       Date:  1995-05       Impact factor: 5.226

6.  The relationship between phospholipid content and Ca2+-ATPase activity in the sarcoplasmic reticulum.

Authors:  S Pikuła; L Epstein; A Martonosi
Journal:  Biochim Biophys Acta       Date:  1994-11-23

7.  Rats clearing a vaginal infection by Candida albicans acquire specific, antibody-mediated resistance to vaginal reinfection.

Authors:  A Cassone; M Boccanera; D Adriani; G Santoni; F De Bernardis
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

8.  Circulating CD4 and CD8 T cells have little impact on host defense against experimental vaginal candidiasis.

Authors:  P L Fidel; M E Lynch; J D Sobel
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

9.  Borrelia burgdorferi bind to epithelial cell proteoglycans.

Authors:  R D Isaacs
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

10.  Penetration and damage of endothelial cells by Candida albicans.

Authors:  S G Filler; J N Swerdloff; C Hobbs; P M Luckett
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

View more
  14 in total

1.  Increased susceptibility of secretor factor gene Fut2-null mice to experimental vaginal candidiasis.

Authors:  Elizabeth A Hurd; Steven E Domino
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

Review 2.  Beyond Candida albicans: Mechanisms of immunity to non-albicans Candida species.

Authors:  Natasha Whibley; Sarah L Gaffen
Journal:  Cytokine       Date:  2015-08-11       Impact factor: 3.861

Review 3.  Candida-host interactions in HIV disease: implications for oropharyngeal candidiasis.

Authors:  P L Fidel
Journal:  Adv Dent Res       Date:  2011-04

4.  Candida-induced oral epithelial cell responses.

Authors:  E A Lilly; J E Leigh; S H Joseph; P L Fidel
Journal:  Mycopathologia       Date:  2006-07       Impact factor: 2.574

5.  Vaginal and oral epithelial cell anti-Candida activity.

Authors:  Fatema Nomanbhoy; Chad Steele; Junko Yano; Paul L Fidel
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

6.  Annexin-A1 identified as the oral epithelial cell anti-Candida effector moiety.

Authors:  E A Lilly; J Yano; P L Fidel
Journal:  Mol Oral Microbiol       Date:  2010-08       Impact factor: 3.563

Review 7.  Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.

Authors:  Louis de Repentigny; Daniel Lewandowski; Paul Jolicoeur
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

8.  Transcriptional responses of candida albicans to epithelial and endothelial cells.

Authors:  Hyunsook Park; Yaoping Liu; Norma Solis; Joshua Spotkov; Jessica Hamaker; Jill R Blankenship; Michael R Yeaman; Aaron P Mitchell; Haoping Liu; Scott G Filler
Journal:  Eukaryot Cell       Date:  2009-08-21

9.  Cervical mucins carry alpha(1,2)fucosylated glycans that partly protect from experimental vaginal candidiasis.

Authors:  Steven E Domino; Elizabeth A Hurd; Kristina A Thomsson; David M Karnak; Jessica M Holmén Larsson; Elisabeth Thomsson; Malin Bäckström; Gunnar C Hansson
Journal:  Glycoconj J       Date:  2009-12       Impact factor: 2.916

Review 10.  Immune defence mechanisms and immunoenhancement strategies in oropharyngeal candidiasis.

Authors:  Cristina Cunha Villar; Anna Dongari-Bagtzoglou
Journal:  Expert Rev Mol Med       Date:  2008-10-13       Impact factor: 5.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.